Literature DB >> 20688015

Precipitating factors and the outcome of hepatic encephalopathy in liver cirrhosis.

Khalid Mumtaz1, Umair Syed Ahmed, Shahab Abid, Noshaba Baig, Saeed Hamid, Wasim Jafri.   

Abstract

OBJECTIVE: To determine precipitants of hepatic encephalopathy (HE) and their impact on hospital stay and mortality. STUDY
DESIGN: Cross-sectional, analytical study. PLACE AND DURATION OF STUDY: The Aga Khan University Hospital, from January 2005 to December 2007.
METHODOLOGY: Consecutive patients admitted with different grades of HE were evaluated between January 2005 and December 2007. The precipitants of HE were correlated with the different grades of HE, and length of hospital stay and mortality. Chi-square test was used to compare the proportion of precipitating factors versus hospital stay and grade with significance at p<0.05.
RESULTS: Of the 404 patients 252 (62%) were males. Hepatitis C virus was the cause of cirrhosis in 283 (70%); Child Turcotte Pugh (CTP) class C was present in 317 (78%) patients. On presentation, 17% patients had grade 1 HE while 44%, 29% and 10% had grades 2, 3 and 4 respectively. The most common precipitant of HE was spontaneous bacterial peritonitis in 83 (20.5%), constipation in 74 (18.3%) and urinary tract infection in 62 (15.3%). One hundred and forty (35%) patients had (3) 2 precipitating factors while no precipitant was noted in 50 (12%) patients. Mean hospital stay was 4+/-3 days. The lesser the number of precipitants, shorter was the length of stay (p<0.01) and lesser was the grade of HE (p=0.025). Complete reversal of HE was noted in 366 patients (91%) while the remaining had grade 1 HE on discharge. Nine (2.2%) patients died during the hospital stay. No mortality was noted in patients without precipitants.
CONCLUSION: Patients presenting with (3) 2 precipitating factors and advanced grade of HE had a prolonged hospital stay. Moreover, patients without precipitants had better outcomes.

Entities:  

Mesh:

Year:  2010        PMID: 20688015     DOI: 08.2010/JCPSP.514518

Source DB:  PubMed          Journal:  J Coll Physicians Surg Pak        ISSN: 1022-386X            Impact factor:   0.711


  11 in total

1.  Current concepts in the pathophysiology and management of hepatic encephalopathy.

Authors:  R Todd Frederick
Journal:  Gastroenterol Hepatol (N Y)       Date:  2011-04

2.  Gastroesophageal reflux in cirrhotic patients without esophageal varices.

Authors:  Jun Zhang; Pei-Lin Cui; Dong Lv; Shi-Wei Yao; You-Qing Xu; Zhao-Xu Yang
Journal:  World J Gastroenterol       Date:  2011-04-07       Impact factor: 5.742

3.  Hyponatremia and Its Correlation With Hepatic Encephalopathy and Severity of Liver Disease.

Authors:  Amna Younas; Junaid Riaz; Tamoor Chughtai; Hamza Maqsood; Muhammad Saim; Shaheryar Qazi; Shifa Younus; Umar Ghaffar; Muhammad Khaliq
Journal:  Cureus       Date:  2021-02-06

4.  Ammonia modifies enteric neuromuscular transmission through glial γ-aminobutyric acid signaling.

Authors:  David E Fried; Ralph E Watson; Simon C Robson; Brian D Gulbransen
Journal:  Am J Physiol Gastrointest Liver Physiol       Date:  2017-08-24       Impact factor: 4.052

Review 5.  Advances in cirrhosis: Optimizing the management of hepatic encephalopathy.

Authors:  Andy Liu; Ryan B Perumpail; Radhika Kumari; Zobair M Younossi; Robert J Wong; Aijaz Ahmed
Journal:  World J Hepatol       Date:  2015-12-18

6.  A New Look at Precipitants of Overt Hepatic Encephalopathy in Cirrhosis.

Authors:  Ganesh Pantham; Anthony Post; Deepak Venkat; Douglas Einstadter; Kevin D Mullen
Journal:  Dig Dis Sci       Date:  2017-05-30       Impact factor: 3.199

7.  Effect of renal function impairment on the mortality of cirrhotic patients with hepatic encephalopathy: a population-based 3-year follow-up study.

Authors:  Tsung-Hsing Hung; Chih-Wei Tseng; Kuo-Chih Tseng; Yu-Hsi Hsieh; Chih-Chun Tsai; Chen-Chi Tsai
Journal:  Medicine (Baltimore)       Date:  2014-09       Impact factor: 1.889

8.  Precipitating Factors and Treatment Outcomes of Hepatic Encephalopathy in Liver Cirrhosis.

Authors:  Nandu S Poudyal; Sitaram Chaudhary; Sudhamshu Kc; Bidhan N Paudel; Bhupendra K Basnet; Amrendra Mandal; Paritosh Kafle; Baikuntha Chaulagai; Azad Mojahedi; Mukesh S Paudel; Barun Shrestha; Vijay Gayam
Journal:  Cureus       Date:  2019-04-02

9.  Acute Changes in Mentation in a Patient with Hepatic Cirrhosis Treated with High Doses of Dexamethasone.

Authors:  Luis Dabul; Andrew Droney; Juan Oms; Marcos A Sanchez-Gonzalez
Journal:  Cureus       Date:  2017-09-10

10.  Temporal trends of cirrhosis associated conditions.

Authors:  Tomoki Sempokuya; Guangxiang Zhang; Kazuma Nakagawa
Journal:  World J Hepatol       Date:  2019-01-27
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.